CeQur has announced recently that the FDA has granted 510(k) clearance for its Simplicity system for an extended wear duration. Simplicity, a...
Vous n'êtes pas connecté
CamDiab has received authorisation from the Food and Drug Administration (FDA) in the US for its advanced adaptive hybrid closed-loop app, CamAPS FX, as an ‘interoperable automated glycaemic controller device’ The Android app helps to manage glucose levels in people with Type 1 diabetes by allowing a compatible insulin pump and a compatible continuous glucose […]
CeQur has announced recently that the FDA has granted 510(k) clearance for its Simplicity system for an extended wear duration. Simplicity, a...
SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.
The Realme 13 Pro+ 5G was launched today for the global market with it being an updated device to the Realme 12 Pro+ 5G which was launched just last...
Research shows that using only the common casual blood glucose test for gestational diabetes screening misses most cases, prompting calls for better...
FRIDAY, Sept. 27, 2024 -- Casual blood glucose (CBG) testing at 24 to 28 gestational weeks misses about 70 percent of women with gestational diabetes...
The FDA approves MRK's Keytruda for first-line treatment of malignant pleural mesothelioma. This marks Keytruda's first approval for the given...
Nevro announces the FDA approval and limited market release of HFX iQ with HFX AdaptivAI.
By integrating ultra-rapid acting insulin such as Lyumjev, which responds faster than traditional insulin, Tandem Diabetes Care is enhancing the...
Biomea stock rises 9% after the FDA lifts clinical hold on two phase I/II studies evaluating the company's lead candidate, BMF-219, for diabetes.